Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Scientists have discovered how iron in lysosomes can induce ferroptosis, offering a new route to target treatment-resistant ...

Cornelia Tischmacher's road to survival led from Germany to the United States, where she received a double-lung transplant at ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

A new medication offers hope for treating a challenging type of lung cancer, as revealed by an international clinical trial ...

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

Revolution Medicines reports positive data for KRAS-targeting cancer drug elironrasib, showing higher response rates vs Amgen's Lumakras & Bristol Myers' Krazati ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

In the recent study, Ramalingam found that people with Stage III lung cancer who had EGFR mutations had an 84% lower risk of ...

Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...

Nuvation Bio's taletrectinib shows strong efficacy in ROS1-positive NSCLC, with a 90.1% response rate. Click here to find out ...

Our lungs are fairly susceptible to diseases. Unlike most other organs, the lungs are in direct contact with the outside ...